PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Designer microbe shows promise for reducing mercury absorption from seafood

UCLA and UCSD research suggests a probiotic could one day increase the benefits of eating fish

2025-05-01
(Press-News.org) Key takeaways

· UCLA and UCSD scientists inserted DNA-encoding methylmercury detoxification enzymes into the genome of an abundant human gut bacterium. The engineered bacterium detoxified methylmercury in the gut of mice and dramatically reduced the amount that reached other tissues, such as the brain and liver.

· Mice given an oral probiotic containing the engineered microbe and fed a diet high in bluefin tuna had much lower methylmercury levels than expected, suggesting that a probiotic might eventually make it safer for people to consume fish.

· Researchers performed the tests using pregnant mice and found lower levels of methylmercury in both maternal and fetal tissues, and lower signs of mercury toxicity in the fetal brain.

UCLA and UCSD scientists inserted DNA-encoding methylmercury detoxification enzymes into the genome of an abundant human gut bacterium. The engineered bacterium detoxified methylmercury in the gut of mice and dramatically reduced the amount that reached other tissues, such as the brain and liver.

Mice given an oral probiotic containing the engineered microbe and fed a diet high in bluefin tuna had much lower methylmercury levels than expected, suggesting that a probiotic might eventually make it safer for people to consume fish.

Researchers performed the tests using pregnant mice and found lower levels of methylmercury in both maternal and fetal tissues, and lower signs of mercury toxicity in the fetal brain.

An engineered gut microbe can detoxify methylmercury, reducing the amount that passes into the brain and developing fetuses of mice fed a diet rich in fish, UCLA and UC San Diego’s Scripps Institution of Oceanography scientists have discovered.

“We envision the possibility that people could take a probiotic to offset the risk of consuming too much methylmercury, especially when pregnant,” said UCLA associate professor and director of the UCLA Goodman-Luskin Microbiome Center Elaine Hsiao, who is the senior author of a paper describing the research in the journal Cell Host & Microbe.

Mercury is a pollutant that enters water from several sources, the largest of which are human activities such as coal burning, artisanal gold mining and smelting, and wastes

from consumer products. In the ocean, mercury transforms into a toxic form called methylmercury. It also biomagnifies, meaning that methylmercury concentrations in animal tissues increase up the food chain from algae-eaters to top predators like humans.

This means that all the methylmercury in something an organism eats goes into its tissues and is passed on to whatever eats it. Organisms near the top of their food chains, like bluefin tuna and humans, acquire all the mercury accumulated by the previous links in the chain. Thus, people who primarily eat food containing high mercury levels are at higher risk of mercury poisoning and birth defects.

“Despite global efforts to reduce mercury emissions and its accumulation in fish, methylmercury levels in seafood are not expected to decline anytime soon. Fish remains a major and culturally important part of the diet for many people around the world and we hope it continues to be,” said co-senior author and Scripps associate professor of marine biogeochemistry Amina Schartup.

Researchers modified Bacteroides thetaiotaomicron, a naturally abundant bacterium in the human digestive tract, by inserting DNA-encoding mercury detoxification enzymes from a mercury-resistant soil bacterium. After confirming that the engineered bacteria could clear methylmercury in a test tube, they replaced the natural gut microbiomes of mice with the modified bacteria and orally administered a large amount of methylmercury all at once. The mice had lower levels of methylmercury in their intestines just three hours after, and the level continued to fall for four days, showing that the bacteria helped to effectively eliminate the methylmercury in the intestine.

They next asked whether the engineered bacteria would be effective at decreasing tissue methylmercury levels when exposure occurs gradually through routine dietary intake. To test this, the researchers fed the mice diets containing bluefin tuna over a period of days and found that not only did the bacteria reduce mercury in the intestine just as well, but less entered the brain and liver, too.

They then tested pregnant mice and found lower levels of methylmercury in both maternal and fetal tissues, and lower signs of mercury toxicity in the fetal brain.

“By reducing dietary methylmercury in the intestine, the gut bacteria helped to eliminate it from the body before it could enter the maternal bloodstream and access the developing offspring,” said first author and UCLA research scientist Kristie Yu.

Co-author and UCLA researcher Franciscus Chandra said that the lowered signs of toxicity in the fetal brain showed that the bacterium works at levels that are biologically meaningful.

When the team repeated the experiments with salmon, which contains lower levels of methylmercury than in bluefin tuna, the bacterium was also effective.

Finally, they fed the bacteria as an oral probiotic to mice with intact microbiomes and fed them the same bluefin tuna diet as the mice in the previous experiment. Under these conditions, the engineered bacteria were also remarkably effective at minimizing the amount of methylmercury that entered tissues, suggesting that one day, a probiotic could be developed to reduce the risks of a fish-based diet.

The researchers were supported by funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development; the National Institute of Environmental Health Sciences; the National Science Foundation; the Research Corporation of Scientific Advancement; the Simons Foundation; and the Packard Foundation.

Hsiao and Schartup are working on improving the efficacy of the bacterium and moving closer to translation to humans, an endeavor for which continued federal funding is critical.

END


ELSE PRESS RELEASES FROM THIS DATE:

Sex- and race-specific prevalence of hearing loss across the adult lifespan and associated factors

2025-05-01
About The Study: The prevalence and degree of hearing loss were highest among white male individuals and lowest among Black female individuals in this cohort study of 1,787 adults. Some factors associated with hearing loss, including noise exposure, differed across sex-specific and race-specific groups. Hearing loss is an important public health concern that could be addressed through tailored interventions to reduce its risk across populations. Corresponding Author: To contact the corresponding author, Lauren K. Dillard, PhD, AuD, email dillalau@musc.edu. To ...

Ptero firma: Footprints pinpoint when ancient flying reptiles conquered the ground

2025-05-01
Fossils of footprints over 160 million years old have helped palaeontologists at the University of Leicester to narrow down when pterosaurs adapted to live on the ground. These awe-inspiring flying reptiles of the Mesozoic era are often imagined soaring over the heads of dinosaurs. But new research shows that some of these ancient creatures were just as comfortable walking on the ground. In a groundbreaking new study published today in Current Biology (1 May), scientists at the University of Leicester have ...

New research from Mass General Brigham guides treatment regimen for aggressive blood cancer

2025-05-01
Study data reveal how a specific sequence of cancer therapies can improve outcomes for patients with hard-to-treat lymphomas Relapsed/refractory (R/R) mature T and natural killer (NK)-cell lymphomas (TNKL) are aggressive blood cancers often resistant to frontline therapies. A team of Mass General Brigham researchers found that patients with these lymphomas had improved survival rates when treated with small molecule inhibitors as second-line therapy, followed by epigenetic modifiers as third-line therapy. Results of the study are published in the British Journal of Haematology. “Our robust ...

USC team develops a powerful new analytical tool to advance CAR T cell therapy research

2025-05-01
A team of researchers from the Keck School of Medicine of USC has developed an advanced tool for analyzing chimeric antigen receptor (CAR) T cells, including how they evolve during manufacturing and which ones are most effective at killing cancer. Using the platform, which leverages a laser-based technology known as spectral flow cytometry, researchers have already found one key insight: CAR T cells are better equipped to fight cancer after a shorter five-day expansion process than at the 10-day mark. The study was just published in the 25th anniversary special issue of Molecular Therapy, the flagship journal of the American Society of Gene & Cell Therapy. CAR ...

Boosting NAD+ levels slows aging in cells from Werner syndrome patients

2025-05-01
“Our results indicated compromised NAD+ metabolism in WS while NAD+ augmentation decreased senescence in both WS mesenchymal stem cells (MSCs) and primary fibroblasts, shedding light on potential therapeutics.” BUFFALO, NY — May 1, 2025 — A new research paper was published in Aging (Aging-US) on April 2, 2025, as the cover of Volume 17, Issue 4, titled “Decreased mitochondrial NAD+ in WRN deficient cells links to dysfunctional proliferation.” In this study, the team led by first author Sofie Lautrup ...

JMIR Rehabilitation and Assistive Technologies invites submissions on advancing telerehabilitation research and innovation

2025-05-01
(Toronto, May 1, 2025) JMIR Publications invites submissions to a new theme issue titled “The Importance of Telerehabilitation and Future Directions for the Field” in its open access journal JMIR Rehabilitation and Assistive Technologies. The premier, peer-reviewed journal is indexed in PubMed/PubMed Central, SCOPUS, DOAJ, Web of Science, Sherpa/Romeo and EBSCO/EBSCO Essentials. The field of telerehabilitation has rapidly evolved, demonstrating its effectiveness, feasibility, and safety across various medical conditions. As outlined ...

Seven stroke advocates recognized nationwide for resilience and community impact

2025-05-01
DALLAS, May 1, 2025 — Every 40 seconds someone in the U.S. has a stroke[1], one of the leading causes of serious, long-term disability. To spotlight the courage and dedication of those impacted by stroke, the American Stroke Association, a division of the American Heart Association, is honoring seven nationwide recipients through its annual Stroke Hero Awards. The awards celebrate stroke survivors, caregivers, health care professionals and advocates who are advancing awareness, education and support for the stroke community nationwide. ...

The National Multiple Sclerosis Society commits over $18 million for research to drive pathways to cures

2025-05-01
The National Multiple Sclerosis Society has committed $18.1 million in multi-year funding to support research projects aligned with its Pathways to Cures roadmap that focuses on three critical areas: stopping MS, restoring function and ending MS.  The new projects include 16 research grants and 28 training fellowships and early career awards in the United States and internationally. The Society is committed to driving the best, most promising science and to training the next generation of pioneering MS researchers. More than 100 senior scientists from research institutions around the country, and a special committee ...

Virtual pulmonary rehabilitation programs are safe, effective for people with COPD

2025-05-01
Miami (May 1, 2025) – Virtual pulmonary rehabilitation is a safe, effective alternative to traditional pulmonary rehabilitation programs for people with chronic obstructive pulmonary disease (COPD) who also require supplemental oxygen, according to a new report. The report is published in the March 2025 issue of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, a peer-reviewed, open-access journal. COPD is an inflammatory lung disease, comprising several conditions, including ...

Good karma for me, bad karma for you

2025-05-01
WASHINGTON – Many people around the world believe in karma – that idea that divine justice will punish people who do bad deeds and reward those who good. But that belief plays out differently for oneself versus others, according to research published by the American Psychological Association. People are more likely to believe that they’ve earned good things in their own life through karmic merit, while bad things that happen to other people are due to karmic punishment, according ...

LAST 30 PRESS RELEASES:

May issues of APA journals feature research on better depression care, improving mental health in disaster-affected communities, school-based prevention efforts, and more

Press registration and scientific program now available for atomic, molecular, and optical physics meeting

A digestive ‘treasure chest’ shows promise for targeted drug treatment in the gut

New ASU-Science prize recognizing research focused on societal impact open for submissions

North American birds are disappearing fastest where they are most abundant

Males are more likely to get sick and less likely to seek care for three common diseases

Revealed: The geometrical “frustrations” that shape growing rose petals

Adaptation and sluggish gene flow cannot save mountain plants from climate change

A symbiotic gut fungus wards off liver disease in mice

Study shows how millions of bird sightings unlock precision conservation

Origins of common lung cancer that affects smokers discovered

Breakthrough provides new hope for patients with knee osteoarthritis

Shelters at bus stops intended to provide relief from heat can actually result in higher temperatures, UTHealth Houston researchers discover

With CCTA poised to transform PCI planning, SCAI/SCCT publish expert opinion document

GLP-1 studies add to growing body of evidence demonstrating significant benefit on cardiovascular outcomes

Alarming rise in cardiovascular deaths for those with obesity disproportionately impacting minorities and women

Rhythmically trained sea lion returns for an encore—and performs as well as humans

Study of facial bacteria could lead to probiotics that promote healthy skin

Racial and ethnic disparities in receipt of ERBB2-targeted therapy for breast cancer

Designer microbe shows promise for reducing mercury absorption from seafood

Sex- and race-specific prevalence of hearing loss across the adult lifespan and associated factors

Ptero firma: Footprints pinpoint when ancient flying reptiles conquered the ground

New research from Mass General Brigham guides treatment regimen for aggressive blood cancer

USC team develops a powerful new analytical tool to advance CAR T cell therapy research

Boosting NAD+ levels slows aging in cells from Werner syndrome patients

JMIR Rehabilitation and Assistive Technologies invites submissions on advancing telerehabilitation research and innovation

Seven stroke advocates recognized nationwide for resilience and community impact

The National Multiple Sclerosis Society commits over $18 million for research to drive pathways to cures

Virtual pulmonary rehabilitation programs are safe, effective for people with COPD

Good karma for me, bad karma for you

[Press-News.org] Designer microbe shows promise for reducing mercury absorption from seafood
UCLA and UCSD research suggests a probiotic could one day increase the benefits of eating fish